In this research work, we built and ensembled different EGFR microdeletion mutations' based Artificial Neural Networks(ANNs) for improved diagnosis of Non-Small Cell Lung Cancer(NSCLC). We developed two novel algorithms, namely; Genomic Nucleotide Encoding & Normalization (GNEN) algorithm to encode and normalize the EGFR nucleotides and SimMicrodel algorithm to programmatically simulate microdeletion mutations. Sample patients' data with microdeletion mutations were extracted from online EGFR mutation databases and the two novel algorithms (implemented in MATLAB) were applied to these data to generate appropriate data sets for training and testing of the networks.
Pathologists determine the type of lung cancer by looking at a biopsy of tumor cells under the microscope. There are two major types of lung cancer which are; non-small cell lung cancer(NSCLC) and small cell lung cancer(SCLC). NSCLC accounts for about 85% of lung cancers while the remaining 15% are SCLC [3, 4] . A spectrum of mutations exists within Neural Network model for pattern recognition in medical diagnosis was described by Frenster, J.H. in [14] . G. Wilym et al in [15] developed an efficient neural network model for the diagnosis of carcinogenesis.
A system that employed an artificial neural network to detect suspicious regions in a low-resolution image was described in [18] . An automatic pathological diagnosis procedure named Neural Ensemble based Detection (NED) was implemented with an artificial neural network ensemble by Zhi-Hua Zhou et al in [19] .
However in this work, nucleotides of the EGFR's deletion mutations were utilized to train and test different ANNs.
These ANNs are ensembled to achieve an optimal informatics platform for the diagnosis of NSCLC. Section two of this paper explains the materials and methods we utilised in the research, section three discusses our experimental results while section four draws conclusions on the paper.
MATERIALS AND METHODS
The Tyrosine kinase(TK) domain is the region of the EGFR gene that is proned to mutation in NSCLC patients. The TK domain has 7 exons(exons 18-24), out of which exons 18-21 carry various somatic mutations in NSCLC patients [20] .
The nucleotide ranges for exons 18 -21 of the TK domain are shown in The benefit of artificial neural networks (ANNs) as decision making tools in the field of cancer was described in [16] .
Chiou et al designed an ANN based system named HLND(hybrid lung cancer detection) to improve the accuracy of diagnosis and the speed of lung cancerous pulmonary radiology [17] . Table 2 details the genomic profiles of NSCLC patients with microdeletion mutations that we extracted from [20] . The data in the table corroborate facts from other literatures on oncogenomics for the mutation patterns in NSCLC patients. that may be introduced into the diagnostics system randomly and dynamically.
The Genomics Nucleotides Encoding and Normalization(GNEN) Algorithm
To comply with the mathematical structure of each ANN layer, input and output data is normally structured as a string or vector of numbers. One of the challenges in using ANNs is mapping how the real-world input/output(e.g. an image, a Table 3 ). Table 3 . GNEN output for the four EGFR nucleotides and microdeletion mutations. 
The Artificial Neural Network(ANN) Architecture for our Genomics Based ANNs

The Microdeletion Mutations ANNs
Using the simulated and normalised genomic patterns with our novel algorithms (SimMicrodel and GNEN) and also the architecture in Figure 4 , different ANNs were built based on each of the exons in EGFR's TK domain that are susceptible to mutation in our sample data( exons 18 -20) . 
RESULTS AND DISCUSION
The training datasets of the genomics based ANNs are shown in Table 4 (Table 4) is detailed in Table 5 .
Levenberg-Marquardt algorithm was used for all the experiments because our study in [22] shows that it is the best backpropagation training algorithm for the genomics based ANN.
After proper training,the various patient categories in the testing dataset were subjected to different configurations of the ANN for 5 different experiments. The outcomes of the tests are shown in Table 6 . Table 7 shows the details of the errors and the minimum errors for each patient category. Tables 7 and 8 
CONCLUSION
